期刊
EXPERT REVIEW OF VACCINES
卷 10, 期 2, 页码 211-226出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.10.161
关键词
analogue; epitope; MHC; peptide; peptidomimetic; TCR; vaccine
类别
资金
- Australian Research Council [LP0883541]
- National Health and Medical Research Council of Australia [508927, 508929]
- Australian Research Council [LP0883541] Funding Source: Australian Research Council
Peptide vaccines represent a potential strategy for the prevention and treatment of pathogenic diseases, cancers and autoimmune disorders; their low cost, ease of synthesis and inherent safety are all attractive features. However, they have remained largely unsuccessful owing to low immunogenicity, predominantly stemming from reduced bioavailability due to rapid proteolytic degradation in vivo. The field of peptidomimetics, through chemical alteration of epitope structure, attempts to modify peptides to engender improved immunogenicity and stability, with the ultimate aim of rationally designing more efficacious vaccines. This article discusses the strategies employed in this process and recent advances within the field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据